Medicines pricing and reimbursement: innovation, competitiveness, and access

Adriana M. IVAMA-BRUMMELL, Daniella PINGRET-KIPMAN, Claudia S. OSORIO-DE-CASTRO, Jaime ESPÍN, Vania C. CANUTO-SANTOS, Romilson A. VOLOTÃO, Augusto A. GUERRA-JUNIOR, Gabriela B. MOSEGUI
2022 Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde  
Access to medicines is a key component for ensuring the universal right to health and for "Promoting health throughout the life cycle and universal health coverage (UHC)", one of the Sustainable Development Goals (SDG). It accounts for one of the main health expenditures. Most new medicines, which are increasingly expensive, do not always offer added therapeutic benefits in relation to existing options, nor are the benefits proportional to their high prices. 1 At the same time, incentives to
more » ... ntain old, safe and effective medicines on the market may not be present.
doi:10.30968/rbfhss.2022.131.0679 doaj:87ce02a5097a460aa77b838b0b1c99f6 fatcat:ts2rgeogzfc75e3yc23luwptuq